Nipah@20: Lessons Learned from Another Virus with Pandemic Potential-Reference-Cited by-同舟云学术

Nipah@20: Lessons Learned from Another Virus with Pandemic Potential

Published:2020-08-26 Issue:4 Volume:5 Page:
ISSN:2379-5042
Container-title:mSphere
language:en
Short-container-title:mSphere

Author:

Gómez Román Raúl¹,Wang Lin-Fa²^ORCID,Lee Benhur³^ORCID,Halpin Kim⁴,de Wit Emmie⁵,Broder Christopher C.⁶,Rahman Mahmudur⁷,Kristiansen Paul¹,Saville Melanie¹⁸

Affiliation:

1. Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway

2. Duke-NUS Medical School, Singapore

3. Icahn School of Medicine at Mount Sinai, New York, New York, USA

4. Australian Centre for Disease Preparedness (ACDP), Geelong, Australia

5. Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Hamilton, Montana, USA

6. Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA

7. Independent Consultant, Dhaka, Bangladesh

8. Coalition for Epidemic Preparedness Innovations (CEPI), London, United Kingdom

Abstract

Nipah disease is listed as one of the WHO priority diseases that pose the greatest public health risk due to their epidemic potential. More than 200 experts from around the world convened in Singapore last year to mark the 20th anniversary of the first Nipah virus outbreaks in Malaysia and Singapore. Most of these experts are now involved in responding to the coronavirus disease 2019 (COVID-19) pandemic. Here, members of the Organizing Committee of the 2019 Nipah Virus International Conference review highlights from the Nipah@20 Conference and reflect on key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mSphere.00602-20

Reference17 articles.

1. World Health Organization. 2020. WHO Priority Diseases. World Health Organization Geneva Switzerland. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts.

2. Coalition for Epidemic Preparedness and Innovations. 2019. CEPI Joint Coordination Group Nipah Meeting Summary Singapore December 11 2019. Coalition for Epidemic Preparedness and Innovations Oslo Norway. https://cepi.net/wp-content/uploads/2020/01/JCG-Nipah-Meeting-Summary.pdf.

3. Coalition for Epidemic Preparedness and Innovations. 2019. Nipah@20. Proceedings from Nipah Virus International Conference Singapore 9 to 11 December 2019. https://cepi.net/wp-content/uploads/2020/06/2019-CEPI-Duke-WHO-NIAID-Nipah-Conference_FINAL.pdf.

4. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

5. Rational Vaccine Design in the Time of COVID-19

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced accuracy and reliability in predicting Nipah virus outbreaks with Type-1 and Type-2 fuzzy sets;Biomedical Signal Processing and Control;2024-12

2. Epidemiological features and psychoneurological consequences of infection of people with the Nipah virus;HIV Infection and Immunosuppressive Disorders;2024-09-05

3. Recent Advances in Immunological Landscape and Immunotherapeutic Agent of Nipah Virus Infection;Cell Biochemistry and Biophysics;2024-07-25

4. Measures to prevent and treat Nipah virus disease: research priorities for 2024–29;The Lancet Infectious Diseases;2024-07

5. Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein;Nature Communications;2024-05-31